CYTOMED THERAPEUTICS LIMITED

Q2 2026 13F Holders

Symbol
GDTC
CUSIP
Y1R80M106
Type
Equity
Class
SHS
Num filers
3
Total reported value, excl. options
$12.2k
Manager Report Date Value ($000) Shares Option Type